Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 125-128

  Nakamura, Junji ^a   Imai, Eiici ^a   Yoshihama, Makoto ^a   Sasano, Hironodu ^b   Kubota, Tetsuro ^c  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Aromatase inhibitor; Breast cancer; Histoculture

Indexed keywords

ANTIINFECTIVE AGENT; AROMATASE; AROMATASE INHIBITOR; NKSO1; TESTOSTERONE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENZYME INHIBITION; ENZYME SUBSTRATE; EPITHELIUM CELL; FEMALE; HISTOCULTURE DRUG RESPONSE ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0031946265     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hoffman RM: Three-dimentional histoculture: origins and applications in cancer research. Cancer cells 3: 86-92, 1991.
2. Hoffman RM: Histoculture and the immunodeficient mouse come to the cancer clinic: Rational approaches to individualizing cancer therapy and new drug evaluation. Int J Oncol 1: 467-474, 1992.
3. Falkson G, Raats JI and Fallcson HC: Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer. J Steroid Biochem Mol Biol 43: 161-165, 1992.
4. Iveson TJ, Smith IE and Trunet PF: Phase I study of the oral nonsteroidal aromatase inhibitor CGS20267. in postmenopausal patients with advanced breast cancer. Cancer Res 53: 266-270, 1993.
5. Miller WR and O'Neil J: The importance of local synthesis of estrogen with the breast. Steriods 50:537-548, 1987.
6. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R and Santner SJ: Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627-632, 1994.
7. Sasano H, Nagura H, Harada N, Goukon Y and Kimura M: Immunolocalization of aromatase and other steroidogenic enzyme in human breast disorders. Hum Pathol 25:530-535, 1994.
8. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE and Chen S: Detection of intratumoral aromatase in breast carcinomas. Am J Pathol 140: 337-343, 1992.
9. Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G and Brodie A: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancer. Endocrinology 137: 3061-3068, 1996.
10. Sasano H, Maehara I, Ueno J, Orikasa S and Nagura H: Leydig cell tumor of the testis: analysis of testosterone production and secretion by three-demensional histoculture. Endocrine J 43: 73-78 1996.
11. Yoshihama M, Nakakoshi M, Tamura K, Miyata N, Kawanishi G and lida M: Microbial production of two new dihydroxylated androstenedione derivatives by Acremonium strictum. J Ferm Bioeng 67: 238-243, 1989.
12. Kitawaki J, Fukuoka M, Yamamoto T, Honjo H and Okada H: Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J Steroid Biochem Mol Biol 42: 267-277, 1992.
13. Bezwoda WR, Mansoor N, Dansey R and Esser JD: Aromatization of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. Oncology 44: 30-33, 1987.
14. Lipton A, Santen R J, Santner SJ, Prognostic value of breast cancer aromarase. Cancer 70: 1951-1955, 1992.
15. Silva MC, Rowlards MG, Dowsett M: Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49: 2588-2591, 1989.
16. Bezwoda WR, Dansey R, Hesdorffer C and Browde S: Use of aminoglutethimide for the treatment of advanced breast cancer: clinical correlation with prior treatment, ER and menstrual status. S Afr Med J 72: 107-109, 1987.
17. Bezwoda WR, Mansoor N and Dansey R: Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology 44: 345-349, 1987.
18. Bradlow HL: A reassessment of role of breast tumor aromatization. Cancer Res 42(Suppl): 3382s-3386s, 1982.